Dr. Helen X. Xu, MD

Dr. Xu practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Xu's NPI, 1881701639, was assigned on August 25, 2006. Dr. Xu graduated from Zhejiang Medical University in 1986. Dr. Xu holds California license A83955.

Dr. Xu's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Xu's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Xu is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Xu to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Xu practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Xu's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Xu is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Xu's licenses on file in 2 states: California and Minnesota.

Dmand AI lists ear eustachian tube disorders, ear infection, hearing loss and impairment, tinnitus and vertigo among the conditions Dr. Xu treats.

CMS data shows 239 Medicare services from Dr. Xu across 7 procedure codes in 2024, for 171 Medicare patients. Medicare paid $14,437 for them.

CMS counts 171 Medicare patients who saw Dr. Xu in 2024. The largest group is 65 to 74, with 73 patients. 71% of them have high cholesterol, and 70% have high blood pressure. 61% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Xu's median patient age at 55, with 58% women.

In 2024, Dr. Xu wrote 124 Medicare Part D claims for 64 patients. 95% of them were for generic drugs. CMS names the drug for 32 of them, across 1 drug with 11 or more claims each, at $326 in total drug cost. In 2023, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Xu for performance year 2024, reported as part of a group. Dr. Xu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Xu, published from 2011 to 2019. 2012 was the busiest year, with 3. The most frequent topics are Otologic Surgical Procedures, Hearing Loss, Sensorineural and Noise. Dr. Xu has published most often in Ear Nose Throat J. Dr. Xu's most frequent co-authors are Cherine Heesun Kim, MD, Eugene Peter Snissarenko, MD and Shruti Siddharth Joglekar, MD.

Dmand AI links Dr. Xu to 1 clinical trial. Conditions studied include Earache and Laryngopharyngeal Reflux.

CMS Open Payments shows 12 general payments to Dr. Xu from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 56% of the total. Zimmer Biomet Holdings, Inc. paid the most, $379.

Dmand AI lists 1 award for Dr. Xu, most recently CMS Stage 1 EHR in 2013.

Dr. Xu graduated from Zhejiang Medical University in 1986.

Dr. Xu is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.